Author

E. Szegezdi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Conforte· 2 shared P. Krebs· 2 shared A. Bursali· 1 shared A. Oner· 1 shared C. Riether· 1 shared D. G. Helvaci· 1 shared D. Sag· 1 shared E. O'Reilly· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Conforte

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content

S. Gunalp, D. G. Helvaci, A. Oner, A. Bursali, A. Conforte, H. Guner, G. Karakulah, E. Szegezdi, D. Sag

bioRxiv · Aug 16, 2023 · PreprintImmunology

Natural killer cell-mimic nanoparticles can actively target and kill acute myeloid leukemia cells

H. Alizadeh Zeinabad, W. J. Yeoh, M. Lomora, Y. Banz, C. Riether, P. Krebs, E. Szegezdi

This study develops NK cell-mimic nanoparticles that target and kill AML cells by combining TRAIL cytotoxicity and CD16-based antibody recognition.

bioRxiv · Sep 9, 2022Cancer Biology

Single-cell characterisation of the hematopoietic bone marrow interactome in health and disease

S. Ennis, A. Conforte, E. O'Reilly, T. Cichocka, S. Pal Dhami, P. Nicholson, P. Krebs, P. O Broin, E. Szegezdi

The paper characterizes the hematopoietic bone marrow interactome in health and acute myeloid leukemia using single-cell gene expression data, revealing dysregulated ligand-receptor interactions and the role of TGFB1 in AML progression.

bioRxiv · May 13, 2022 · PreprintCancer Biology